Nuclear Medicine/Radiopharmaceutic Market Report

China Nuclear Medicine/Radiopharmaceutic Industry Market Research Report 2023-2029

  • POSTDATE：Oct 05, 2023
  • PAGES：136
  • REPORT CODE：GMM1829691
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Nuclear Medicine/Radiopharmaceutic industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ciaeriar

    • Europe

    • China

    • Eczacibasi-Monrol Nuclear Products

    • Lantheus Medical Imaging

    • Dongcheng

    • Iba Molecular Imaging

    • Jaco

    • Europe

    • Nordion

    • Bracco Imaging

    • China

    • GE Healthcare

    • Advanced Molecular-imaging Solution

    • Europe

    • Europe

    • Cardinal Health

    • China

    • Shanghai Atom Kexing

    • Mallinckrodt

    • Advanced Accelerator Applications

    • Bayer Healthcare

    • China Isotope Radiation

    By Type:

    • Diagnostic

    • Therapeutic

    By Application:

    • Others

    • Cardiology

    • Oncology

    • Thyroid

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Nuclear Medicine/Radiopharmaceutic Market Overview 2018-2029

    • 1.1 China Nuclear Medicine/Radiopharmaceutic Industry Development Overview

    • 1.2 China Nuclear Medicine/Radiopharmaceutic Industry Development History

    • 1.3 China Nuclear Medicine/Radiopharmaceutic Industry Market Size (2018-2029)

    • 1.4 China Nuclear Medicine/Radiopharmaceutic Market Analysis by Type from Production Side

      • 1.4.1 China Nuclear Medicine/Radiopharmaceutic Production Volume, Production Value and Growth Rate of Diagnostic (2018-2029)

      • 1.4.2 China Nuclear Medicine/Radiopharmaceutic Production Volume, Production Value and Growth Rate of Therapeutic (2018-2029)

    • 1.5 China Nuclear Medicine/Radiopharmaceutic Market Analysis by Application from Consumption End

      • 1.5.1 China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

      • 1.5.3 China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.4 China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Thyroid (2018-2029)

    • 1.6 China Nuclear Medicine/Radiopharmaceutic Market Analysis by Region

      • 1.6.1 North China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    Chapter 2 China Nuclear Medicine/Radiopharmaceutic Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Nuclear Medicine/Radiopharmaceutic Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Nuclear Medicine/Radiopharmaceutic Market Status and Competition Analysis in 2023

      • 2.2.3 China Nuclear Medicine/Radiopharmaceutic Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Nuclear Medicine/Radiopharmaceutic Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Nuclear Medicine/Radiopharmaceutic Industry Development

    Chapter 3 Nuclear Medicine/RadiopharmaceuticIndustry Chain Analysis

    • 3.1 Nuclear Medicine/Radiopharmaceutic Industry Chain

    • 3.2 Nuclear Medicine/Radiopharmaceutic Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Nuclear Medicine/Radiopharmaceutic Market

    • 3.3 Nuclear Medicine/Radiopharmaceutic Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Nuclear Medicine/Radiopharmaceutic Market

    Chapter 4 China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 4.1 China Nuclear Medicine/Radiopharmaceutic Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Nuclear Medicine/Radiopharmaceutic Total Production Volume and Growth Rate from Production Side

    • 4.5 China Nuclear Medicine/Radiopharmaceutic Production Volume and Growth Rate, by Type

      • 4.5.1 China Nuclear Medicine/Radiopharmaceutic Production Volume and Growth Rate of Diagnostic

      • 4.5.2 China Nuclear Medicine/Radiopharmaceutic Production Volume and Growth Rate of Therapeutic

    Chapter 5 China Nuclear Medicine/Radiopharmaceutic Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Nuclear Medicine/Radiopharmaceutic Total Market Size and Growth Rate from Consumption End

    • 5.5 China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate, by Application

      • 5.5.1 China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Others

      • 5.5.2 China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Cardiology

      • 5.5.3 China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Oncology

      • 5.5.4 China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Thyroid

    Chapter 6 China Nuclear Medicine/Radiopharmaceutic Market, by Region

    • 6.1 China Nuclear Medicine/Radiopharmaceutic Production Volume and Production Value, by Region

    • 6.2 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Sales Value, by Region

    Chapter 7 North China Nuclear Medicine/Radiopharmaceutic Market Analysis

    • 7.1 North China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 7.2 North China Nuclear Medicine/Radiopharmaceutic Market, by Application

    Chapter 8 Central China Nuclear Medicine/Radiopharmaceutic Market Analysis

    • 8.1 Central China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 8.2 Central China Nuclear Medicine/Radiopharmaceutic Market, by Application

    Chapter 9 South China Nuclear Medicine/Radiopharmaceutic Market Analysis

    • 9.1 South China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 9.2 South China Nuclear Medicine/Radiopharmaceutic Market, by Application

    Chapter 10 East China Nuclear Medicine/Radiopharmaceutic Market Analysis

    • 10.1 East China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 10.2 East China Nuclear Medicine/Radiopharmaceutic Market, by Application

    Chapter 11 Northeast China Nuclear Medicine/Radiopharmaceutic Market Analysis

    • 11.1 Northeast China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 11.2 Northeast China Nuclear Medicine/Radiopharmaceutic Market, by Application

    Chapter 12 Southwest China Nuclear Medicine/Radiopharmaceutic Market Analysis

    • 12.1 Southwest China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 12.2 Southwest China Nuclear Medicine/Radiopharmaceutic Market, by Application

    Chapter 13 Northwest China Nuclear Medicine/Radiopharmaceutic Market Analysis

    • 13.1 Northwest China Nuclear Medicine/Radiopharmaceutic Market, by Type

    • 13.2 Northwest China Nuclear Medicine/Radiopharmaceutic Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ciaeriar

        • 14.1.1 Ciaeriar Company Profile

        • 14.1.2 Ciaeriar Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Europe

        • 14.2.1 Europe Company Profile

        • 14.2.2 Europe Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 China

        • 14.3.1 China Company Profile

        • 14.3.2 China Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eczacibasi-Monrol Nuclear Products

        • 14.4.1 Eczacibasi-Monrol Nuclear Products Company Profile

        • 14.4.2 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Lantheus Medical Imaging

        • 14.5.1 Lantheus Medical Imaging Company Profile

        • 14.5.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Dongcheng

        • 14.6.1 Dongcheng Company Profile

        • 14.6.2 Dongcheng Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Iba Molecular Imaging

        • 14.7.1 Iba Molecular Imaging Company Profile

        • 14.7.2 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Jaco

        • 14.8.1 Jaco Company Profile

        • 14.8.2 Jaco Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Europe

        • 14.9.1 Europe Company Profile

        • 14.9.2 Europe Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Nordion

        • 14.10.1 Nordion Company Profile

        • 14.10.2 Nordion Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Bracco Imaging

        • 14.11.1 Bracco Imaging Company Profile

        • 14.11.2 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 China

        • 14.12.1 China Company Profile

        • 14.12.2 China Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 GE Healthcare

        • 14.13.1 GE Healthcare Company Profile

        • 14.13.2 GE Healthcare Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Advanced Molecular-imaging Solution

        • 14.14.1 Advanced Molecular-imaging Solution Company Profile

        • 14.14.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Europe

        • 14.15.1 Europe Company Profile

        • 14.15.2 Europe Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Europe

        • 14.16.1 Europe Company Profile

        • 14.16.2 Europe Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Cardinal Health

        • 14.17.1 Cardinal Health Company Profile

        • 14.17.2 Cardinal Health Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 China

        • 14.18.1 China Company Profile

        • 14.18.2 China Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Shanghai Atom Kexing

        • 14.19.1 Shanghai Atom Kexing Company Profile

        • 14.19.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Mallinckrodt

        • 14.20.1 Mallinckrodt Company Profile

        • 14.20.2 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Advanced Accelerator Applications

        • 14.21.1 Advanced Accelerator Applications Company Profile

        • 14.21.2 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Bayer Healthcare

        • 14.22.1 Bayer Healthcare Company Profile

        • 14.22.2 Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 China Isotope Radiation

        • 14.23.1 China Isotope Radiation Company Profile

        • 14.23.2 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Market Performance

        • 14.23.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Nuclear Medicine/Radiopharmaceutic Industry Research Conclusions

    • 15.2 Nuclear Medicine/Radiopharmaceutic Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Nuclear Medicine/Radiopharmaceutic Industry Market Size (2018-2029)

    • Figure China Nuclear Medicine/Radiopharmaceutic Production Volume, Production Value and Growth Rate of Diagnostic (2018-2029)

    • Figure China Nuclear Medicine/Radiopharmaceutic Production Volume, Production Value and Growth Rate of Therapeutic (2018-2029)

    • Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

    • Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume, Sales Value and Growth Rate of Thyroid (2018-2029)

    • Figure North China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    • Figure Central China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    • Figure South China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    • Figure East China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate from 2018-2029

    • Figure Nuclear Medicine/Radiopharmaceutic Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2018

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2023

    • Figure China Nuclear Medicine/Radiopharmaceutic Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Production Volume and Growth Rate of Diagnostic (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Production Volume and Growth Rate of Therapeutic (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2018

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2023

    • Figure China Nuclear Medicine/Radiopharmaceutic Total Market Size and Growth Rate from Consumption End

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Others (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Cardiology (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Thyroid (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Production Volume by Region (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Region (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Region (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Production Value by Region (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Production Value Share by Region (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Production Value Share by Region (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales Volume by Region (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Region (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Region (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales Value by Region (2018-2023)

    • Table China Nuclear Medicine/Radiopharmaceutic Sales Value Share by Region (2018-2023)

    • Figure China Nuclear Medicine/Radiopharmaceutic Sales Value Share by Region (2018-2023)

    • Table North China Nuclear Medicine/Radiopharmaceutic Production Volume by Type (2018-2023)

    • Table North China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Figure North China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Table North China Nuclear Medicine/Radiopharmaceutic Sales Volume by Application (2018-2023)

    • Table North China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Figure North China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Table Central China Nuclear Medicine/Radiopharmaceutic Production Volume by Type (2018-2023)

    • Table Central China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Figure Central China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Table Central China Nuclear Medicine/Radiopharmaceutic Sales Volume by Application (2018-2023)

    • Table Central China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Figure Central China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Table South China Nuclear Medicine/Radiopharmaceutic Production Volume by Type (2018-2023)

    • Table South China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Figure South China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Table South China Nuclear Medicine/Radiopharmaceutic Sales Volume by Application (2018-2023)

    • Table South China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Figure South China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Table East China Nuclear Medicine/Radiopharmaceutic Production Volume by Type (2018-2023)

    • Table East China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Figure East China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Table East China Nuclear Medicine/Radiopharmaceutic Sales Volume by Application (2018-2023)

    • Table East China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Figure East China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Table Northeast China Nuclear Medicine/Radiopharmaceutic Production Volume by Type (2018-2023)

    • Table Northeast China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Figure Northeast China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Table Northeast China Nuclear Medicine/Radiopharmaceutic Sales Volume by Application (2018-2023)

    • Table Northeast China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Table Southwest China Nuclear Medicine/Radiopharmaceutic Production Volume by Type (2018-2023)

    • Table Southwest China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Figure Southwest China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Table Southwest China Nuclear Medicine/Radiopharmaceutic Sales Volume by Application (2018-2023)

    • Table Southwest China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Table Northwest China Nuclear Medicine/Radiopharmaceutic Production Volume by Type (2018-2023)

    • Table Northwest China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Figure Northwest China Nuclear Medicine/Radiopharmaceutic Production Volume Share by Type (2018-2023)

    • Table Northwest China Nuclear Medicine/Radiopharmaceutic Sales Volume by Application (2018-2023)

    • Table Northwest China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Nuclear Medicine/Radiopharmaceutic Sales Volume Share by Application (2018-2023)

    • Table Ciaeriar Company Profile

    • Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Europe Company Profile

    • Table Europe Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table China Company Profile

    • Table China Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Eczacibasi-Monrol Nuclear Products Company Profile

    • Table Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Lantheus Medical Imaging Company Profile

    • Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Dongcheng Company Profile

    • Table Dongcheng Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Iba Molecular Imaging Company Profile

    • Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Jaco Company Profile

    • Table Jaco Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Europe Company Profile

    • Table Europe Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Nordion Company Profile

    • Table Nordion Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Bracco Imaging Company Profile

    • Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table China Company Profile

    • Table China Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table GE Healthcare Company Profile

    • Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Advanced Molecular-imaging Solution Company Profile

    • Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Europe Company Profile

    • Table Europe Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Europe Company Profile

    • Table Europe Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Cardinal Health Company Profile

    • Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table China Company Profile

    • Table China Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Shanghai Atom Kexing Company Profile

    • Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Mallinckrodt Company Profile

    • Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Advanced Accelerator Applications Company Profile

    • Table Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table Bayer Healthcare Company Profile

    • Table Bayer Healthcare Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)

    • Table China Isotope Radiation Company Profile

    • Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US